Brief online pain therapy for fibromyalgia, lupus, pelvic pain and low back pain
Tests a short video-call talking therapy for adults with long-lasting pain conditions.
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Registry title
- Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- Status
- Recruiting
- People taking part
- 125 people, planned
- Started
- 4 Mar 2024
- Expected to end
- Jul 2027
- Type of study
- Interventional
- Treatments tested
- Brief pain exposure therapy (BPET)
- Record updated
- 11 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with fibromyalgia, lupus, chronic pelvic pain or chronic low back pain. They will test a short talk-based treatment for pain held over Zoom.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Fibromyalgia: a doctor's diagnosis, or the 2016 ACR criteria, or pain in 4 of 7 body regions plus a doctor's diagnosis of opioid use disorder. Lupus: a doctor's diagnosis of systemic lupus erythematosus and pain in 4 of 7 body regions. Chronic low back pain: pain on at least half the days over the past 6 months and average pain of at least 4 out of 10 over the past 7 days.
- Earlier treatment
- Lupus group: no change in medicines or steroid dose for one month before entry. People now getting cognitive-behavioral therapy or other talk therapy for pain cannot join.
Main reasons for not taking part
- Another cause of long-term pain, such as inflammatory arthritis, other autoimmune disorders, spinal cord injury or cancer
- Being pregnant or breastfeeding
- An open lawsuit about chronic pain in the past 1 year
- Lupus group: taking more than 10 mg prednisone (or a similar steroid) per day
- Pelvic pain group: surgery for pelvic pain in the past 6 months; back pain group: back surgery planned, or leg pain worse than back pain
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Able to read, write and speak English
- Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home; Fibromyalgia participants must have:
- Physician diagnosis of fibromyalgia
- OR: meet 2016 American College of Rheumatology (ACR) Criteria for FM: Widespread pain index score is ≥ 7 and symptom severity scale score is ≥ 5, or widespread pain index score is 4 to 6 and symptom severity score is ≥ 9
- OR: have pain self-reported in 4 out of 7 body regions in the General Sensory Sensitivity (GSS)-brief body map AND Opioid Use Disorder diagnosis by a physician; Lupus participants must have:
- Physician diagnosis of systemic lupus erythematosus
- AND: Have pain self-reported in 4 out of 7 body regions in the GSS-brief body map
- AND: No change in medications or steroid dose for one month prior to entry (to avoid oscillation of steroid dosing during the study due to active disease); Chronic Low Back Pain participants must have:
- Low Back Pain for at least half the days over the past 6 months
- Over the past 7 days, an average pain intensity of at least 4 out of 10
Who cannot take part
- Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
- Chronic low back pain only: scheduled back surgery; leg pain that is greater than your back pain
- Indication of a co-occurring (non-fibromyalgia OR non-lupus) cause of chronic pain (e.g., inflammatory arthritis, other autoimmune disorders, spinal cord injury, cancer)
- Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols
- Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators
- Lupus group only: taking >10 mg prednisone (or equivalent steroid) dose per day as an indicator of ongoing disease activity (with no other strict exclusions based on medications)
- Chronic Pelvic Pain group only: surgery for any chronic pelvic pain related condition in the past 6 months
- Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening
- Pregnant or breastfeeding
Where in United States
- University of MichiganAnn Arbor, United StatesContact: Beth BannerTaking people
About the trial
What the trial wants to find out
This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).
The group in the trial
- Brief pain exposure therapy (BPET)Treatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- Plain-language title
- Brief online pain therapy for fibromyalgia, lupus, pelvic pain and low back painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 11 May 2026